BEVACIZUMAB (AVASTIN)1.25mg/0.05mL recall
FDA recall D-0051-2025 · initiated Nov 6, 2024
Tailstorm Health INC recalled BEVACIZUMAB (AVASTIN)1.25mg/0.05mL in Nov 2024 — an FDA Class II recall (D-0051-2025) because Lack of Sterility Assurance.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Lack of Sterility Assurance
Sterility could not be assured
The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 27,560 Syringes
Details
- Product
- BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1
- Recalling company
- Tailstorm Health INC
- Classification
- Class II
- Status
- Terminated
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide Within U.S.
- Initiated
- Nov 6, 2024
- FDA report date
- Nov 27, 2024
Frequently asked
- Was BEVACIZUMAB (AVASTIN)1.25mg/0.05mL recalled?
- Tailstorm Health INC recalled BEVACIZUMAB (AVASTIN)1.25mg/0.05mL in Nov 2024 — an FDA Class II recall (D-0051-2025) because Lack of Sterility Assurance. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was BEVACIZUMAB (AVASTIN)1.25mg/0.05mL recalled?
- Per the FDA enforcement record, the reason for recall D-0051-2025 was: Lack of Sterility Assurance
- Is a recalled BEVACIZUMAB (AVASTIN)1.25mg/0.05mL dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of BEVACIZUMAB (AVASTIN)1.25mg/0.05mL are affected?
- Distributed: Nationwide Within U.S.. The recall covers these lots — Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0051-2025.